Presynaptic adaptive responses to constitutive versus adult pharmacologic inhibition of serotonin uptake

Experimental Models in Serotonin Transporter Research

Volumn , Issue , 2010, Pages 1-42

  Luellen, Beth A ^a   Gilman, Tracy L ^a   Andrews, Anne Milasincic ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956195933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511729935.002     Document Type: Chapter

References (166)

1. Altamura C, Dell’Acqua M L, Moessner R, Murphy D L, Lesch K P, Persico A M (2007). Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb Cortex 17: 1394-401.
2. Amargos-Bosch M, Artigas F, Adell A (2005). Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. Eur J Pharmacol 516: 235-8.
3. Andersen S L, Dumont N L, Teicher M H (2002). Differences in behavior and monoamine laterality following neonatal clomipramine treatment. Dev Psy- chobiol 41: 50-7.
4. Andrews A M, Ladenheim B, Epstein C J, Cadet J L, Murphy D L (1996). Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2’-NH2-MPTP on serotonergic and noradrenergic nerve terminals. Mol Pharmacol 50: 1511-9.
5. Ansorge M S, Morelli E, Gingrich J A (2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199-207.
6. Ansorge M S, Zhou M, Lira A, Hen R, Gingrich J A (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-81.
7. Arborelius L, Nomikos G G, Hertel P, et al. (1996). The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn Schmiedebergs Arch Pharmacol 353: 630-40.
8. Bel N, Artigas F (1993). Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15: 243-5.
9. Bel N, Artigas F (1996). In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. J Pharmacol Exp Ther 278: 1064-72.
10. Bengel D, Johren O, Andrews A M, et al. (1997). Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res 778: 338-45.
11. Bengel D, Murphy D L, Andrews A M, et al. (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-55.
12. Benmansour S, Cecchi M, Morilak D A, et al. (1999). Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19: 10494-501.
13. Benmansour S, Owens W A, Cecchi M, Morilak D A, Frazer A (2002). Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22: 6766-72.
14. Blakely R D, Defelice L J, Galli A (2005). Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda) 20: 225-31.
15. Bosker F J, Cremers T I, Jongsma M E, Westerink B H, Wikstrom H V, den Boer J A (2001). Acute and chronic effects of citalopram on postsynaptic 5-hydroxy- tryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala. J Neurochem 76: 1645-53.
16. Bosker F J, Klompmakers A A, Westenberg H G (1995a). Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34: 501-8.
17. Bosker FJ, van Esseveldt KE, Klompmakers A A, Westenberg H G (1995b). Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berl) 117: 358-63.
18. Brunello N, Riva M, Volterra A, Racagni G (1987). Effect of some tricyclic and nontricyclic antidepressants on [3H]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam Clin Pharmacol 1: 327-33.
19. Burnet P W, Michelson D, Smith M A, Gold P W, Sternberg E M (1994). The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res 638: 311-24.
20. Caccia S, Fracasso C, Garattini S, Guiso G, Sarati S (1992). Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 31: 343-7.
21. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16: 297-307.
22. Caspi A, Sugden K, Moffitt T E, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-9.
23. Castren E (2004). Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4: 58-64.
24. Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi R W (2004). Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. Br J Pharmacol 142: 469-78.
25. Cheetham S C, Viggers J A, Slater N A, Heal D J, Buckett W R (1993). [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32: 737-43.
26. Chefer V I, Zapata A, Shippenberg T S, Bungay P M (2006). Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J Neurosci Meth 155: 187-93.
27. Dawson L A, Nguyen H Q, Smith D I, Schechter L E (2000). Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study. Br J Pharmacol 130: 797-804.
28. Dawson L A, Nguyen H Q, Smith D L, Schechter L E (2002). Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16: 145-52.
29. Donovan S L, Mamounas L A, Andrews A M, Blue M E, McCasland J S (2002). GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J Neurosci 22: 3543-52.
30. Durand M, Berton O, Aguerre S, et al. (1999). Effects of repeated fluoxetine on anxiety-related behaviors, central serotonergic systems, and the cortico- tropic axis axis in SHR and WKY rats. Neuropharmacology 38: 893-907.
31. Fabre V, Beaufour C, Evrard A, et al. (2000). Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12: 2299-310.
32. Ferrer A, Artigas F (1994). Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur J Pharmacol 263: 227-34.
33. Fredricson Overo K (1982). Kinetics of citalopram in test animals; drug exposure in safety studies. Prog Neuropsychopharmacol Biol Psychiatry 6: 297-309.
34. Gardier A M, David D J, Jego G, et al. (2003). Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. J Neurochem 86: 13-24.
35. Gartside S E, Leitch M M, Young A H (2003). Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 28: 1572-8.
36. Gobbi M, Crespi D, Foddi M C, et al. (1997). Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356: 22-8.
37. Golembiowska K, Dziubina A (2000). Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52: 441-8.
38. Gould G G, Altamirano A V, Javors M A, Frazer A (2006). A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry 59: 408-14.
39. Gould G G, Javors M A, Frazer A (2007). Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biol Psychiatry 61: 210-5.
40. Grabe H J, Lange M, Wolff B, et al. (2005). Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10: 220-4.
41. Graham D, Tahraoui L, Langer S Z (1987). Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26: 1087-92.
42. Greenberg B D, Li Q, Lucas F R, et al. (2000). Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96: 202-16.
43. Greenberg B D, Tolliver T J, Huang S J, Li Q, Bengel D, Murphy D L (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88: 83-7.
44. Gross C, Zhuang X, Stark K, et al. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behavior in the adult. Nature 416: 396-400.
45. Gundlah C, Hjorth S, Auerbach S B (1997). Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36: 475-82.
46. Gur E, Dremencov E, Lerer B, Newman M E (1999a). Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 372: 17-24.
47. Gur E, Dremencov E, Van De Kar L D, Lerer B, Newman M E (2002a). Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. Eur J Pharmacol 436: 57-65.
48. Gur E, Lerer B, Newman M E (1999b). Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity. J Pharmacol Exp Ther 288: 81-7.
49. Gur E, Lifschytz T, Lerer B, Newman M E (2002b). Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. Eur J Pharmacol 457: 37-43.
50. Gur E, Lifschytz T, Van De Kar L D, Lerer B, Newman M E (2004). Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine. Psychoneuroendocrinology 29: 1172-83.
51. Hajos-Korcsok E, McTavish S F, Sharp T (2000). Effect of a selective 5-hydroxytryp- tamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur J Pharmacol 407: 101-7.
52. Hansen H H, Sanchez C, Meier E (1997). Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming- induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 283: 1333-41.
53. Heils A, Teufel A, Petri S, et al. (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-4.
54. Hervas I, Vilaro M T, Romero L, Scorza M C, Mengod G, Artigas F (2001). Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24: 11-20.
55. Hiemke C, Hartter S (2000). Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85: 11-28.
56. Hilakivi L A, Hilakivi I (1987). Increased adult behavioral ‘despair’ in rats neonatally exposed to desipramine or zimeldine: an animal model of depression? Pharmacol Biochem Behav 28: 367-9.
57. Hirano K, Seki T, Sakai N, et al. (2005). Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res 1053: 154-61.
58. Hjorth S, Auerbach S B (1994). Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33: 331-4.
59. Hjorth S, Auerbach S B (1999). Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Res 835: 224-8.
60. Holmes A, Lit Q, Murphy D L, Gold E, Crawley J N (2003a). Abnormal anxiety- related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2: 365-80.
61. Holmes A, Yang R J, Lesch K P, Crawley J N, Murphy D L (2003b). Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28: 2077-88.
62. Homberg J R, Olivier J D, Smits B M, et al. (2007). Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146: 1662-76.
63. Horschitz S, Hummerich R, Schloss P (2001). Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor. Neuroreport 12: 2181-4.
64. Hrdina P D (1987). Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants. Eur J Pharmacol 138: 159-68.
65. Hrdina P D, Vu T B (1993). Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14: 324-31.
66. Hwang E C, Magnussen I, Van Woert M H (1980). Effects of chronic fluoxetine administration on serotonin metabolism. Res Commun Chem Pathol Pharmacol 29: 79-98.
67. Iceta R, Mesonero J E, Alcalde AI (2007). Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells. Life Sci 80: 1517-24.
68. Invernizzi R, Bramante M, Samanin R (1995). Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res 696: 62-6.
69. Invernizzi R, Bramante M, Samanin R (1996). Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol Biochem Behav 54: 143-7.
70. Invernizzi R W, Parini S, Sacchetti G, et al. (2001). Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex. Br J Pharmacol 132: 183-8.
71. Jennings K A, Loder M K, Sheward W J, et al. (2006). Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 26: 8955-64.
72. Johnson D A, Grant E J, Ingram C D, Gartside S E (2007). Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biol Psychiatry 62: 1228-35.
73. Keck M E, Sartori S B, Welt T, et al. (2005). Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression- like behavior: effects of chronic paroxetine treatment. J Neurochem 92:1170-9.
74. Kehr J (1993). A survey on quantitative microdialysis: theoretical models and practical implications. J Neurosci Meth 48: 251-61.
75. Kihara T, Ikeda M (1995). Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J Pharmacol Exp Ther 272: 177-83.
76. Kim D K, Tolliver T J, Huang S J, et al. (2005). Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49: 798-810.
77. Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T (2005). Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium. Eur J Pharmacol 516: 219-26.
78. Koed K, Linnet K (1997). The serotonin transporter messenger RNA level in rat brain is not regulated by antidepressants. Biol Psychiatry 42: 1177-80.
79. Kovachich G B, Aronson C E, Brunswick D J (1992). Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology 7: 317-24.
80. Kreiss D S, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274: 866-76.
81. Kuroda Y, Watanabe Y, McEwen B S (1994). Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol 268: R3-5.
82. Lau T, Horschitz S, Berger S, Bartsch D, Schloss P (2008). Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons. Faseb J 22: 1702-14.
83. Lesch K P, Aulakh C S, Wolozin B L, Tolliver T J, Hill J L, Murphy D L (1993). Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res 17: 31-5.
84. Lesch K P, Bengel D, Heils A, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-31.
85. Li Q, Ma L, Innis R B, et al. (2004). Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethyl- phenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethyl- aminomethyl-phenylthio)]benzonitrile (DASB). J Pharmacol Exp Ther 308: 481-6.
86. Lifschytz T, Gur E, Lerer B, Newman M E (2004). Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140: 133-9.
87. Lim J E, Papp A, Pinsonneault J, Sadee W, Saffen D (2006). Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry 11: 649-62.
88. Lira A, Zhou M, Castanon N, et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter- deficient mice. Biol Psychiatry 54: 960-71.
89. Lisboa S F, Oliveira P E, Costa L C, Venancio E J, Moreira E G (2007). Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 80: 49-56.
90. Little K Y, McLaughlin D P, Zhang L, et al. (1998). Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155: 207-13.
91. Lonnroth P, Jansson P A, Smith U (1987). A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253: E228-31.
92. Lopez J F, Chalmers D T, Vazquez D M, Watson S J, Akil H (1994). Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35: 287-90.
93. Luellen B A, Bianco L E, Schneider L M, Andrews A M (2007). Reduced brain- derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav 6: 482-90.
94. Luellen B A, Szapacs M E, Materese C K, Andrews A M (2006). The neurotoxin 2’-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF. Neuropharmacology 50: 297-308.
95. Malagie I, Deslandes A, Gardier A M (2000). Effects of acute and chronic tianep- tine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403: 55-65.
96. Mamounas L A, Altar C A, Blue M E, Kaplan D R, Tessarollo L, Lyons W E (2000). BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20: 771-82.
97. Mamounas L A, Blue M E, Siuciak J A, Altar C A (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15: 7929-39.
98. Mamounas LA, Molliver M E (1988). Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol 102: 23-36.
99. Mamounas LA, Mullen C A, O’Hearn E, Molliver M E (1991). Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314: 558-86.
100. Mann J J, Huang Y Y, Underwood M D, et al. (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-38.
101. Mathews T A, Fedele D E, Coppelli F M, Avila A M, Murphy D L, Andrews A M (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140: 169-81.
102. Melzacka M, Rurak A, Adamus A, Daniel W (1984). Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage. Pol J Pharmacol Pharm 36: 675-82.
103. Mirmiran M, van de Poll N E, Corner M A, van Oyen H G, Bour H L (1981). Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204: 129-46.
104. Mirza N R, Nielsen E O, Troelsen K B (2007). Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Prog Neuropsychopharmacol Biol Psychiatry 31: 858-66.
105. Mitchell S N, Greenslade R G, Cooper J (2001). LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat. Eur J Pharmacol 432: 19-27.
106. Montanez S, Owens W A, Gould G G, Murphy D L, Daws L C (2003). Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem 86: 210-9.
107. Moret C, Briley M (1996). Effects of acute and repeated administration of cita- lopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295: 189-97.
108. Murphy D L, Lerner A, Rudnick G, Lesch K P (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4: 109-23.
109. Nakayama K, Katsu H, Ando T, Nakajo R (2003). Possible alteration of tryptophan metabolism following repeated administration of sertraline in the rat brain. Brain Res Bull 59: 293-7.
110. Neumaier J F, Root D C, Hamblin M W (1996). Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 15: 515-22.
111. Neumeister A, Hu X Z, Luckenbaugh D A, et al. (2006). Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63: 978-86.
112. Neumeister A, Konstantinidis A, Stastny J, et al. (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59: 613-20.
113. Newman M E, Gur E, Dremencov E, Garcia F, Lerer B, Van de Kar L D (2000). Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology 39: 2309-17.
114. Newman M E, Shalom G, Ran A, Gur E, Van de Kar L D (2004). Chronic fluoxetine- induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635. Eur J Pharmacol 486: 25-30.
115. Numis A L, Unger E L, Sheridan D L, Chisnell A C, Andrews A M (2004). The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2’-aminophenyl)-1,2,3,6-tetrahydropyri- dine (2’-NH(2)-MPTP). Mol Pharmacol 66: 718-27.
116. Olson Cosford R J, Vinson A P, Kukoyi S, Justice J B, Jr. (1996). Quantitative microdialysis of serotonin and norepinephrine: pharmacological influences on in vivo extraction fraction. J Neurosci Meth 68: 39-47.
117. Owen J C, Whitton P S (2005). Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats. Br J Pharmacol 145: 587-92.
118. Owen J C, Whitton P S (2006). Chronic treatment with antidepressant drugs reversibly alters NMDA mediated regulation of extracellular 5-HT in rat frontal cortex. Brain Res Bull 70: 62-7.
119. Page M E, Lucki I (2002). Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology 27: 237-47.
120. Parsey R V, Hastings R S, Oquendo M A, et al. (2006a). Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163:48-51.
121. Parsey RV, Hastings R S, Oquendo M A (2006b). Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163: 52-8.
122. Parsons L H, Justice J B, Jr. (1994). Quantitative approaches to in vivo brain microdialysis. Crit Rev Neurobiol 8: 189-220.
123. Perez X A, Andrews A M (2005). Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice. Anal Chem 77: 818-26.
124. Perez X A, Bianco L E, Andrews A M (2006). Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: comparison with chrono- amperometry in SERT knockout mice. J Neurosci Meth 154: 245-55.
125. Persico A M, Baldi A, Dell’Acqua M L, et al. (2003). Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport 14: 341-4.
126. Persico A M, Mengual E, Moessner R, et al. (2001). Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21: 6862-73.
127. Pezawas L, Meyer-Lindenberg A, Drabant E M, et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8: 828-34.
128. Pineyro G, Blier P, Dennis T, de Montigny C (1994). Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14: 3036-47.
129. Popa D, Lena C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28: 3546-54.
130. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice L J, Blakely R D (1997). Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17: 45-57.
131. Ramamoorthy S, Blakely R D (1999). Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285: 763-6.
132. Ramamoorthy S, Giovanetti E, Qian Y, Blakely R D (1998). Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273: 2458-66.
133. Ravary A, Muzerelle A, Darmon M, et al. (2001). Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein. Eur J Neurosci 13: 1349-62.
134. Rebsam A, Seif I, Gaspar P (2002). Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J Neurosci 22: 8541-52.
135. Ren-Patterson R F, Cochran L W, Holmes A, Lesch K P, Lu B, Murphy D L (2006). Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol 26: 755-80.
136. Rossi D V, Burke T F, McCasland M, Hensler J G (2008). Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem 105: 1091-9.
137. Rutter J J, Gundlah C, Auerbach S B (1994). Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171: 183-6.
138. Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi R W, Samanin R (1999). Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol 128: 1332-8.
139. Salichon N, Gaspar P, Upton A L, et al. (2001). Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-ht transporter knock-out mice. J Neurosci 21: 884-96.
140. Sayer T J, Hannon S D, Redfern P H, Martin K F (1999). Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment. Br J Pharmacol 126: 1777-84.
141. Schinka J A, Busch R M, Robichaux-Keene N (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9: 197-202.Schmitt A, Mossner R, Gossmann A, et al. (2003). Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter- deficient mice. J Neurosci Res 71: 701-9.
142. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety- related personality traits. Am J Med Genet 127B: 85-9.
143. Shen H W, Hagino Y, Kobayashi H, et al. (2004). Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29: 1790-9.
144. Sora I, Hall F S, Andrews A M, et al. (2001). Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-5.
145. Spurlock G, Buckland P, O’Donovan M, McGuffin P (1994). Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33: 433-40.
146. Stuart J N, Hummon A B, Sweedler J V (2004). The chemistry of thought: neurotransmitters in the brain. Anal Chem 76: 121A-128A.
147. Swan M C, Najlerahim A R, Bennett J P (1997). Expression of serotonin transporter mRNA in rat brain: presence in neuronal and non-neuronal cells and effect of paroxetine. J Chem Neuroanat 13: 71-6.
148. Szabo S T, de Montigny C, Blier P (1999). Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol 126: 568-71.
149. Tachibana K, Matsumoto M, Koseki H, et al. (2006). Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems. J Psychopharmacol 20: 562-9.
150. Tjurmina O A, Armando I, Saavedra J M, Goldstein D S, Murphy D L (2002). Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143: 4520-6.
151. Trigo J M, Renoir T, Lanfumey L, et al. (2007). 3,4-Methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry 62: 669-79.
152. Velazquez-Moctezuma J, Diaz Ruiz O (1992). Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression. Pharmacol Biochem Behav 42: 737-9.
153. Vitalis T, Cases O, Callebert J, et al. (1998). Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol 393: 169-84.
154. Vogel G, Neill D, Hagler M, Kors D (1990). A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14: 85-91.
155. Watanabe Y, Sakai R R, McEwen B S, Mendelson S (1993). Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 615: 87-94.
156. Wegener G, Bandpey Z, Heiberg I L, Mork A, Rosenberg R (2003). Increased extracellular serotonin level in rat hippocampus induced by chronic citalo- pram is augmented by subchronic lithium: neurochemical and behavioral studies in the rat. Psychopharmacology (Berl) 166: 188-94.
157. Wegerer V, Moll G H, Bagli M, Rothenberger A, Ruther E, Huether G (1999). Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J Child Adolesc Psychopharmacol 9: 13-24; discussion 25-6.
158. Wendland J R, Martin B J, Kruse M R, Lesch K P, Murphy D L (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11: 224-6.
159. Whittington R A, Virag L (2006). Isoflurane decreases extracellular serotonin in the mouse hippocampus. Anesth Analg 103: 92-8, table of contents.
160. Wightman R M (2006). Detection technologies. Probing cellular chemistry in biological systems with microelectrodes. Science 311: 1570-4.
161. Wikell C, Apelqvist G, Hjorth S, Kullingsjo J, Bergqvist P B, Bengtsson F (2002). Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy. Eur Neuropsychopharmacol 12: 327-36.
162. Williams S M, Bryan-Lluka L J, Pow D V (2005). Quantitative analysis of immuno- labeling for serotonin and for glutamate transporters after administration of imipramine and citalopram. Brain Res 1042: 224-32.
163. Zalsman G, Huang Y Y, Oquendo M A, et al. (2006). Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163: 1588-93.
164. Zhao S, Edwards J, Carroll J, et al. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion- related behaviors in mice. Neuroscience 140: 321-34.
165. Zhou F C, Lesch K P, Murphy D L (2002). Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942: 109-19.
166. Zhou L, Huang K X, Kecojevic A, Welsh A M, Koliatsos V E (2006). Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain. J Neurochem 96: 396-406.